Wednesday, 24 June 2020

US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - Latest https://ift.tt/3hX2lsF
via

No comments:

Post a Comment

Lower Entry Barriers After Record Antitrust Fine: Alibaba As Shares Rally

Alibaba Group CEO Daniel Zhang said on Monday he does not expect any material impact from the change of exclusivity arrangement imposed by C...